Dedicated to the
Health and Welfare of All Cats
A A A
Font Size
hero-education

Cat Health News Blog

A resource for dedicated cat supporters

Since its start in 2007, Cat Health News has featured the latest information on feline health. The bi-weekly blog is a mix of the most current published research from Winn-funded research and other sources. There are over 875 blog post items and more than 1,000 subscribers through the RSS feed.


icon-blogWinn-funded research is specifically noted by the small green cat.

  • Rush immunotherapy for feline asthma

    Oct 29, 2013
    Chang CH, Cohn LA, Declue AE, Liu H and Reinero CR. Oral glucocorticoids diminish the efficacy of allergen-specific immunotherapy in experimental feline asthma. Vet J. 2013; 197: 268-72.
     
    Allergen-specific rush immunotherapy (RIT) is a promising treatment for feline asthma that may provide a potential cure for this disease. Benefit from this therapy however can take several months. In the mean time, asthmatic cats usually require concurrent glucocorticoid (GC) therapy until RIT takes effect. Researchers from the College of Veterinary Medicine at the University of Missouri investigated the affects of oral GC, inhaled GC, or placebo administration for the first few months during RIT treatment. The researchers hypothesized that inhaled GC would diminish RIT treatment efficacy to a lesser extent than oral medication since inhaled GC intrinsically have less systemic immunosuppressive effects.

    Three groups of cats (6 per group) were initially sensitized to Bermuda grass allergen (BGA) before receiving BGA-specific RIT treatment and then were continually exposed to weekly BGA aerosol challenge during the 9 months treatment. Each group was either given oral GC (prednisolone 10 mg daily), inhaled GC (fluticasone 220 mcg twice daily), or placebo for the first 6 months of RIT treatment. Bronchoalveolar lavage fluid (BALF) percent eosinophils and other immunological assays (IL-5, IL-10, BGA-specific lymphocyte blastogenesis, percent blood T regulatory cells) were performed. Concentration of IL-5 in BALF increased significantly over time in inhaled GC/RIT cats, a finding that needs further investigation. More importantly, BALF percent eosinophils increased significantly over time only in oral GC/RIT cats between months 6 and 9. This result suggests that inhaled GCs are a better choice than oral GCs for decreasing eosinophilic inflammation until RIT normalizes the dysregulated immune system. [GO]

    See also: Reinero C, Byerly J, Berghaus R and al e. Rush immunotherapy in an experimental model of feline allergic asthma. Vet Immunol Immunopathol. 2006; 110: 141-53.

    asthma

    More on cat health:

    Winn Feline Foundation Library
    Find us on Facebook
    Follow us on Twitter
    Pin with us on Pinterest
    Join us on Google+

 

Archives

2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007